FDA Advisory Committee for Pharmaceutical Science Nonclinical Studies Subcommittee

2/15/00


Click here to start


Table of Contents

FDA Advisory Committee for Pharmaceutical Science Nonclinical Studies Subcommittee

Subcommittee Objectives

Evolution of Drug Discovery & Development

Current Development Paradigms

New Paradigm Utility

Stakeholders in Facilitating Early Entry into Clinical Trials

Subcommittee Activities New Technologies

FDA Advisory Committee for Pharmaceutical Science Nonclinical Studies Subcommittee

Author: Pfizer Central Research